Role of microRNAs and pharmacological, pharmacokinetic and pharmacogenetic influences in bortezomib-induced peripheral neuropathy

Recruiting

• Conditions: C90.0; G62.0; Multiple myeloma; Drug-induced polyneuropathy

• Registration Number: DRKS00025422
• Lead Sponsor: niversitätsklinikum Würzburg Neurologische Klinik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 120

Inclusion Criteria

Multiple Myeloma diagnosed according to current IMWG criteria.

Exclusion Criteria

Serious other medical condition that would prevent subject from study participation

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
microRNA 223 Expression via RT-PCR

Secondary Outcome Measures

Name	Time	Method
Expression of PKNOX1